SCHEMBL15445196

SCHEMBL15445196

Cc1ccc(S(=O)(=O)OCN=[N+]=[N-])cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.42
STAT3 P40763 1/20 0.41
ALDH1A1 P00352 6/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
CA1 P00915 3/20 0.39
CA2 P00918 2/20 0.39
CA12 O43570 2/20 0.39
CA9 Q16790 2/20 0.39
CA3 P07451 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
VDR P11473 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39
MAPK1 P28482 2/20 0.39
PKM P14618 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13456779 0.86 CA12 (0.41) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL14363642 0.83 CA12 (0.40) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL16599488 0.82 CA12 (0.39) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL13884657 0.81 CA12 (0.38) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL16898408 0.81 ALDH1A1 (0.42) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL15881370 0.81 CA12 (0.38) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL13497897 0.81 ALDH1A1 (0.42) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL21179227 0.81 CA12 (0.38) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL14845475 0.81 ALDH1A1 (0.42) GAASTAT3ALDH1A1CYP3A4CYP2C9
SCHEMBL16898333 0.81 ALDH1A1 (0.42) GAASTAT3ALDH1A1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12274760-B2 Method for preparing fluorine-18-labeled fluoromethyl-substituted radiopharmaceuticals using selective azide substitution reaction and precursor scavenging BIK THERAPEUTICS INC. (KR) 2025-04-15 US disclosed
WO-2025075958-A1 POLYMER-FUNCTIONALIZED RETICULAR MATERIALS FOR CARBON DIOXIDE CAPTURE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-04-10 WO disclosed
US-20210205482-A1 METHOD FOR PREPARING FLUORINE-18-LABELED FLUOROMETHYL-SUBSTITUTED RADIOPHARMACEUTICALS USING SELECTIVE AZIDE SUBSTITUTION REACTION AND PRECURSOR SCAVENGING LEE, BYUNG CHUL (KR) 2021-07-08 US disclosed
EP-3842405-A1 METHOD FOR PREPARING FLUORINE-18-LABELED FLUOROMETHYL-SUBSTITUTED RADIOPHARMACEUTICALS USING SELECTIVE AZIDE SUBSTITUTION REACTION AND PRECURSOR SCAVENGING BIK Therapeutics Inc. (KR) 2021-06-30 EP disclosed
WO-2020059986-A1 METHOD FOR PREPARING FLUORINE-18-LABELED FLUOROMETHYL-SUBSTITUTED RADIOPHARMACEUTICALS USING SELECTIVE AZIDE SUBSTITUTION REACTION AND PRECURSOR SCAVENGING 주식회사 바이오이미징코리아 2020-03-26 WO disclosed
US-8637711-B2 Selective and specific preparation of discrete PEG compounds QUANTA BIODESIGN, LTD. (US) 2014-01-28 US disclosed
US-7888536-B2 Selective and specific preparation of discrete PEG compounds QUANTA BIODESIGN, LTD. (US) 2011-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210205482-A1 METHOD FOR PREPARING FLUORINE-18-LABELED FLUOROMETHYL-SUBSTITUTED RADIOPHARMACEUTICALS USING SELECTIVE AZIDE SUBSTITUTION REACTION AND PRECURSOR SCAVENGING KCNK18, CYP4F8, CYP2F1 GAA 3666/4885STAT3 4136/4885ALDH1A1 4358/4885
US-12274760-B2 Method for preparing fluorine-18-labeled fluoromethyl-substituted radiopharmaceuticals using selective azide substitution reaction and precursor scavenging KCNK18, CYP4F8, CYP2F1 GAA 3666/4885STAT3 4136/4885ALDH1A1 4358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.